The inclusion or exclusion of NF-1 patients, variation in patient age and tumor status (newly diagnosed or recurrent), in addition to versatility in tumor site and response to treatment’s definitions, and progression interpretation all restrict comparisons across various CT regimens. Here, NF1 is linked to neoplasm.